Gynecologic Oncology
-
Drug combos enhance ovarian cancer cell death
Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. Read MoreAug 11, 2015
-
Overcoming resistance in ovarian cancer
The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read MoreAug 22, 2013
-
A drug combo for ovarian cancer
Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer. Read MoreDec 24, 2012